- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
51 Bladder Cancer Trials Near You
Power is an online platform that helps thousands of Bladder Cancer patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerBlood Test and Immunotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
992 Participants Needed
Gemcitabine + Docetaxel vs BCG for Bladder Cancer
Trial Details
Key Eligibility Criteria
870 Participants Needed
Chemoradiotherapy + Atezolizumab for Bladder Cancer
Trial Details
Key Eligibility Criteria
475 Participants Needed
Cretostimogene Grenadenorepvec for Bladder Cancer
Trial Details
Key Eligibility Criteria
364 Participants Needed
Trial Details
Key Eligibility Criteria
518 Participants Needed
Pembrolizumab + BCG for Bladder Cancer
Trial Details
Key Eligibility Criteria
1397 Participants Needed
BCG Strains +/− Vaccine for Bladder Cancer
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Immunotherapy Combo vs Chemotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
1322 Participants Needed
Futibatinib + Durvalumab for Bladder Cancer
Trial Details
Key Eligibility Criteria
24 Participants Needed
STM-416 for Bladder Cancer
Trial Details
Key Eligibility Criteria
75 Participants Needed
Durvalumab + Chemo/Radiation for Bladder Cancer
Trial Details
Key Eligibility Criteria
95 Participants Needed
Gemcitabine + Cisplatin for Bladder Cancer
Trial Details
Key Eligibility Criteria
271 Participants Needed
Livmoniplimab + Budigalimab for Bladder Cancer
Trial Details
Key Eligibility Criteria
150 Participants Needed
Immunotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
204 Participants Needed
TAR-200 + Cetrelimab for Bladder Cancer
Trial Details
Key Eligibility Criteria
163 Participants Needed
Trial Details
Key Eligibility Criteria
54 Participants Needed
Disitamab Vedotin + Pembrolizumab for Bladder Cancer
Trial Details
Key Eligibility Criteria
372 Participants Needed
Apalutamide for Bladder Cancer
Trial Details
Key Eligibility Criteria
80 Participants Needed
Erdafitinib + Enfortumab Vedotin for Bladder Cancer
Trial Details
Key Eligibility Criteria
30 Participants Needed
3 Tesla MRI for Bladder Cancer
Trial Details
Key Eligibility Criteria
98 Participants Needed
Why Other Patients Applied
"I've tried chemotherapy and radiation but the cancer recurred. My oncologist suggested that I might want to try a clinical trial given my situation. Just starting to research, hoping to learn more."
"I've had radiation and as far as I know I’m in remission, but my brother passed away with the same condition. I don’t mind helping research for a cure... my husband passed away with pancreatic cancer. I've had a stepdaughter that passed away with ovarian cancer at 20. I just think it’s time to knock cancer out! I'd really like to help find better treatments by participating in a trial."
"I had two chemotherapy regímens without success, three surgeries during which the tumor could not be resected. These clinical trials are a light of hope for me and my family (I have a five year old child) and I have read about cases of success in other types of cancer with this treatment. I think that I am a perfect candidate for this tríal. Thank you."
"My mom has cholangiocarcinoma with bone mts (FGFR2 mutation). She really needs this trial to survive. She’s active and her analysis is ok, but we have very limited other options. Hope to work with a high-quality clinic to prolong her quality and duration of life."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Erdafitinib vs Chemotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
107 Participants Needed
Trial Details
Key Eligibility Criteria
87 Participants Needed
STK-012 + Pembrolizumab for Cancer
Trial Details
Key Eligibility Criteria
202 Participants Needed
MAGE-A4ᶜ¹º³²T Therapy for Cancer
Trial Details
Key Eligibility Criteria
71 Participants Needed
Intravesical Enfortumab Vedotin for Bladder Cancer
Trial Details
Key Eligibility Criteria
58 Participants Needed
Atezolizumab + Chemotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
32 Participants Needed
LOXO-435 for Bladder Cancer
Trial Details
Key Eligibility Criteria
535 Participants Needed
Trial Details
Key Eligibility Criteria
152 Participants Needed
Trial Details
Key Eligibility Criteria
314 Participants Needed
Pembrolizumab for Bladder Cancer
Trial Details
Key Eligibility Criteria
739 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Bladder Cancer clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Bladder Cancer clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Bladder Cancer trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Bladder Cancer is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Bladder Cancer medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Bladder Cancer clinical trials?
Most recently, we added Apalutamide for Bladder Cancer, Livmoniplimab + Budigalimab for Bladder Cancer and Futibatinib + Durvalumab for Bladder Cancer to the Power online platform.